Crossover safety study of aprepitant: 2-min injection vs 30-min infusion in cancer patients receiving emetogenic chemotherapy. [electronic resource]
Publication details: OncoTargets and therapy 2019Description: 3277-3284 p. digitalISSN:- 1178-6930
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.